Edgemont Capital Advises On Compass Research Sale to Bioclinica
Edgemont Capital Partners served as exclusive financial advisor to Compass Research in the company’s sale to Bioclinica.
July 27, 2016
BioClinica | Compass Research | Edgemont Capital Partners
ABF Journal